We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Curbing the life-long effects of traumatic brain injury
News

Curbing the life-long effects of traumatic brain injury

Curbing the life-long effects of traumatic brain injury
News

Curbing the life-long effects of traumatic brain injury

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Curbing the life-long effects of traumatic brain injury "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A fall down the stairs, a car crash, a sports injury or an explosive blast can all cause traumatic brain injury (TBI). Patients often recover. But in the days or weeks following the hit, they can develop other serious, chronic conditions, such as depression and thinking and memory problems.


Now scientists report in the journal ACS Nano a potential way to reduce these effects with a neuron-targeting nanoparticle, using an animal model of TBI.


See Also: Impact of traumatic brain injury on long-term memory explored


When someone suffers from a head injury, the damage doesn't necessarily stop after the initial blow. The jolt can cause a cascade of after-effects—such as inflammation and ultimately the death of brain cells—and lead to physical and cognitive conditions that can continue for years. One promising approach to treating these after-effects involves delivering short stretches of RNA that can help shut down this chain reaction. But getting the RNA to the damaged part of the brain is a challenge because of the blood-brain barrier, which separates circulating blood from the fluid around brain cells. Sangeeta Bhatia and her colleagues at the Massachusetts Institute of Technology's Institute for Medical Engineering & Science wanted to see if they could rush therapeutic RNA to targeted brain cells soon after an injury while the blood-brain barrier is weakened.


Learn More: Stem cell combination therapy improves traumatic brain injury outcomes according to study


The team, led by postdoctoral researcher Ester Kwon, engineered nanoparticles to target neurons by borrowing a protein from the rabies virus. They also loaded the particles with a strip of RNA designed to inhibit the production of a protein associated with neuronal cell death. When given to mice intravenously within a day of receiving a brain injury, the nanoparticles left the circulation and accumulated in the damaged tissue. Analysis also showed that the levels of the protein that the researchers were trying to reduce dropped by about 80 percent in the injured brain tissue.


Note: Material may have been edited for length and content. For further information, please contact the cited source.


American Chemical Society   press release


Publication

Kwon EJ et al. Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain Injuries.   ACS Nano, Published Online July 18 2016. doi: 10.1021/acsnano.6b03858


Advertisement